For more than a decade, we’ve forged new paths for gene therapies. We custom design each of our investigational therapies with the goal of addressing the underlying cause of disease at the genetic level. We are currently developing gene therapies for severe genetic diseases and are advancing research to apply new technologies to these and other diseases. More than 170+ patients have received our therapies across 8 clinical trials.
Contact bluebird bio
info@bluebirdbio.com
Visit Website